177 related articles for article (PubMed ID: 11502209)
1. Oxidized low density lipoproteins downregulate LPS-induced platelet-activating factor receptor expression in human monocyte-derived macrophages: implications for LPS-induced nuclear factor-kappaB binding activity.
Hourton D; Stengel D; Chapman MJ; Ninio E
Eur J Biochem; 2001 Aug; 268(16):4489-96. PubMed ID: 11502209
[TBL] [Abstract][Full Text] [Related]
2. Expression of the PAF receptor in human monocyte-derived macrophages is downregulated by oxidized LDL: relevance to the inflammatory phase of atherogenesis.
Stengel D; Antonucci M; Arborati M; Hourton D; Griglio S; Chapman MJ; Ninio E
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):954-62. PubMed ID: 9157961
[TBL] [Abstract][Full Text] [Related]
3. Oxidized low density lipoprotein inhibits interleukin-12 production in lipopolysaccharide-activated mouse macrophages via direct interactions between peroxisome proliferator-activated receptor-gamma and nuclear factor-kappa B.
Chung SW; Kang BY; Kim SH; Pak YK; Cho D; Trinchieri G; Kim TS
J Biol Chem; 2000 Oct; 275(42):32681-7. PubMed ID: 10934192
[TBL] [Abstract][Full Text] [Related]
4. Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages.
Hourton D; Delerive P; Stankova J; Staels B; Chapman MJ; Ninio E
Biochem J; 2001 Feb; 354(Pt 1):225-32. PubMed ID: 11171098
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein-associated paf (LA-paf) was found in washed human platelets and monocyte/macrophage-like U937 cells.
Korth R; Zimmermann K; Richter WO
Chem Phys Lipids; 1994 Apr; 70(2):109-19. PubMed ID: 8033283
[TBL] [Abstract][Full Text] [Related]
6. Porphyromonas gingivalis lipopolysaccharide alters atherosclerotic-related gene expression in oxidized low-density-lipoprotein-induced macrophages and foam cells.
Lei L; Li H; Yan F; Li Y; Xiao Y
J Periodontal Res; 2011 Aug; 46(4):427-37. PubMed ID: 21418223
[TBL] [Abstract][Full Text] [Related]
7. Oxidized low density lipoprotein inhibits lipopolysaccharide-induced binding of nuclear factor-kappaB to DNA and the subsequent expression of tumor necrosis factor-alpha and interleukin-1beta in macrophages.
Ohlsson BG; Englund MC; Karlsson AL; Knutsen E; Erixon C; Skribeck H; Liu Y; Bondjers G; Wiklund O
J Clin Invest; 1996 Jul; 98(1):78-89. PubMed ID: 8690807
[TBL] [Abstract][Full Text] [Related]
8. PAFR activation of NF-κB p65 or p105 precursor dictates pro- and anti-inflammatory responses during TLR activation in murine macrophages.
Ishizuka EK; Filgueiras LR; Rios FJ; Serezani CH; Jancar S
Sci Rep; 2016 Aug; 6():32092. PubMed ID: 27554194
[TBL] [Abstract][Full Text] [Related]
9. Oxidized LDL suppresses NF-kappaB and overcomes protection from apoptosis in activated endothelial cells.
Heermeier K; Leicht W; Palmetshofer A; Ullrich M; Wanner C; Galle J
J Am Soc Nephrol; 2001 Mar; 12(3):456-463. PubMed ID: 11181793
[TBL] [Abstract][Full Text] [Related]
10. Monocyte binding to endothelial cells induced by oxidized phospholipids present in minimally oxidized low density lipoprotein is inhibited by a platelet activating factor receptor antagonist.
Leitinger N; Watson AD; Faull KF; Fogelman AM; Berliner JA
Adv Exp Med Biol; 1997; 433():379-82. PubMed ID: 9561175
[TBL] [Abstract][Full Text] [Related]
11. Lipopolysaccharide up-regulates the expression of Fcalpha/mu receptor and promotes the binding of oxidized low-density lipoprotein and its IgM antibody complex to activated human macrophages.
Feng X; Zhang Y; Xu R; Xie X; Tao L; Gao H; Gao Y; He Z; Wang H
Atherosclerosis; 2010 Feb; 208(2):396-405. PubMed ID: 19682689
[TBL] [Abstract][Full Text] [Related]
12. PAF effects on MCP-1 and IL-6 secretion in U-937 monocytes in comparison with oxLDL and IL-1β effects.
Verouti SN; Fragopoulou E; Karantonis HC; Dimitriou AA; Tselepis AD; Antonopoulou S; Nomikos T; Demopoulos CA
Atherosclerosis; 2011 Dec; 219(2):519-25. PubMed ID: 21920519
[TBL] [Abstract][Full Text] [Related]
13. Platelet-activating factor and oxidized LDL induce immune activation by a common mechanism.
Frostegård J; Huang YH; Rönnelid J; Schäfer-Elinder L
Arterioscler Thromb Vasc Biol; 1997 May; 17(5):963-8. PubMed ID: 9157962
[TBL] [Abstract][Full Text] [Related]
14. Platelet-activating factor induces NF-kappa B activation through a G protein-coupled pathway.
Kravchenko VV; Pan Z; Han J; Herbert JM; Ulevitch RJ; Ye RD
J Biol Chem; 1995 Jun; 270(25):14928-34. PubMed ID: 7797472
[TBL] [Abstract][Full Text] [Related]
15. Blockade of platelet-activating factor receptor attenuates abnormal behaviors induced by phencyclidine in mice through down-regulation of NF-κB.
Tran TV; Park SJ; Shin EJ; Tran HQ; Jeong JH; Jang CG; Lee YJ; Nah SY; Nabeshima T; Kim HC
Brain Res Bull; 2018 Mar; 137():71-78. PubMed ID: 29122692
[TBL] [Abstract][Full Text] [Related]
16. Phagocytosis of apoptotic and necrotic thymocytes is inhibited by PAF-receptor antagonists and affects LPS-induced COX-2 expression in murine macrophages.
de Oliveira SI; Fernandes PD; Amarante Mendes JG; Jancar S
Prostaglandins Other Lipid Mediat; 2006 Jul; 80(1-2):62-73. PubMed ID: 16846787
[TBL] [Abstract][Full Text] [Related]
17. Methyl-β-cyclodextrin suppresses the monocyte-endothelial adhesion triggered by lipopolysaccharide (LPS) or oxidized low-density lipoprotein (oxLDL).
Chen G; Zhou Y; Zhang W; Qin Y; Wei B; Sun Y; Chen Y
Pharm Biol; 2021 Dec; 59(1):1036-1044. PubMed ID: 34362284
[TBL] [Abstract][Full Text] [Related]
18. Oxidative modulation of NF-kappaB signaling by oxidized low-density lipoprotein.
Muroya T; Ihara Y; Ikeda S; Yasuoka C; Miyahara Y; Urata Y; Kondo T; Kohno S
Biochem Biophys Res Commun; 2003 Oct; 309(4):900-5. PubMed ID: 13679058
[TBL] [Abstract][Full Text] [Related]
19. Participation of platelet-activating factor in the lipopolysaccharide-induced liver injury in partially hepatectomized rats.
Sakaguchi T; Nakamura S; Suzuki S; Oda T; Ichiyama A; Baba S; Okamoto T
Hepatology; 1999 Oct; 30(4):959-67. PubMed ID: 10498648
[TBL] [Abstract][Full Text] [Related]
20. Lysophosphatidylcholine (LPC) induces proinflammatory cytokines by a platelet-activating factor (PAF) receptor-dependent mechanism.
Huang YH; Schäfer-Elinder L; Wu R; Claesson HE; Frostegård J
Clin Exp Immunol; 1999 May; 116(2):326-31. PubMed ID: 10337026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
